Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them?

Drugs to prevent organ rejection are not always covered for patients who had transplants before they enrolled in Medicare.

from NYT > Health https://ift.tt/2YLLXS6
via health&fitness